Ibrahim Azar is a medical oncology at Trinity Health Oakland with an interest in lung cancer. He finished his fellowship from Wayne State University/Karmanos Cancer Institute in 2022. He leads the thoracic tumor board at Trinity Health Oakland and participates in the ASCO Stage IV NSCLC guidelines. He ahs received NCI outstanding contributions awards for high enrollment in NCI clinical trials as well as the ASCO Merit Award,